Axonics® to participate in the society for urodynamics, female pelvic medicine & urogenital reconstruction 2021 winter meeting

Irvine, calif.--(business wire)--axonics modulation technologies, inc. (nasdaq: axnx), a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation (snm) devices for the treatment of urinary and bowel dysfunction, today announced it is participating as a platinum sponsor of the society for urodynamics, female pelvic medicine & urogenital reconstruction (sufu) 2021 winter meeting, which is being held virtually from february 25-27. axonics is
AXNX Ratings Summary
AXNX Quant Ranking